A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
Search this article
Journal
-
- Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association / International Gastric Cancer Association, Japanese Gastric Cancer Association [編]
-
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association / International Gastric Cancer Association, Japanese Gastric Cancer Association [編] 22 (2), 344-354, 2019
Tokyo : Springer Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1524232504534792064
-
- NII Article ID
- 40021832780
-
- NII Book ID
- AA11316227
-
- ISSN
- 14363291
-
- NDL BIB ID
- 029560900
-
- Text Lang
- en
-
- NDL Source Classification
-
- ZS34(科学技術--医学--腫瘍・癌)
-
- Data Source
-
- NDL
- CiNii Articles